Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Recherche
  • icone plus

  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte

  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités

3 results

  • Topics : Musculoskeletal diseases
  • Active substance : phosphate
  • Language : Français
Filter
Topic
  • Diseases and conditions (3)
  • Plus ...
    • Musculoskeletal diseases (3)
    • Plus ...
      • Bone and cartilage diseases (2)
      • Joint and rheumatic diseases (1)
    • Pain - Inflammation (1)
  • Diagnostic and therapeutic techniques (2)
  • Plus ...
    • Drug therapy (1)
    • Diagnostic techniques and procedures (1)
    • Plus ...
      • Biology (laboratory tests) (1)
Content type
  • Drugs, devices and medical acts (3)
  • Plus ...
    • Health technology assessment (2)
    • Medicine (1)
Fabricant
  • industriels (1)
Langue
  • Français (3)
Substance active
  • calcitriol (1)
  • carbonate de calcium (1)
  • gelatine (1)
  • phosphate (3)
  • phosphate tricalcique (1)
  • phosphore (1)
  • sodium (1)
More filter Other Filter Icon
Search Export

Drugs, devices and medical acts - 3 results

  • ANTARENE (ibuprofène/ codéine (phosphate de))

    Medicine - Posted on 3/11/2016 - Mis à jour le 12/6/2019
    Add to my selection

  • Reassessment of bone substitutes

    Health technology assessment - Posted on 19/7/2013 - Mis à jour le 17/3/2016
    Download document
    Add to my selection

  • Clinical utility of the measurement of vitamin D

    Health technology assessment - Posted on 30/10/2013
    Download document
    Add to my selection

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
afGhBtukSPSV9af3